Biolinq Shine Displays Glucose Without Needles or Phone

The FDA cleared the needle-free wearable patch in September 2026, after earlier granting it De Novo classification in 2025.

Updated on Nov. 11, 2026 in Diabetes

Biolinq Shine Displays Glucose Without Needles or Phone

Live Poll

Would you use a needle-free glucose patch that shows readings on the device?

Biolinq Shine is a needle-free glucose monitor whose wearable patch uses tiny silicon-based microsensors and shows blood sugar readings on its display without a smartphone. The FDA granted 510(k) clearance to the device in September 2026.

Why it matters

Displaying glucose data directly on a wearable removes the need for a paired smartphone app, which could make continuous monitoring simpler for eligible adults. The device is intended for adults aged 22 and older who are not on insulin.

The only hard figure in the source is the age floor of 22 years for intended users, which defines the device's eligibility group. The source does not provide accuracy or trial results, and clinical performance data remain unreported.

The players

Biolinq

Biolinq is the company that developed the Shine needle-free glucose monitor, co-founded by Jared Tangney and Joshua Windmiller.

U.S. Food and Drug Administration

The FDA is the federal agency that regulates medical devices in the United States and granted Biolinq Shine its De Novo classification and 510(k) clearance.

The details

Biolinq Shine is a wearable patch built on tiny silicon-based microsensors that displays real-time glucose readings directly on the device without a smartphone app. The technology was co-founded by Jared Tangney and Joshua Windmiller and is based on Windmiller's doctoral and postdoctoral research in the lab of UC San Diego professor Joseph Wang.

Timeline

  1. 2025: The FDA grants Biolinq Shine De Novo classification.

  2. September 2026: The FDA grants 510(k) clearance to Biolinq Shine.

  3. 2026: Biolinq Shine is recognised in TIME magazine's Best Inventions of 2026 list.

Roadmap

Biolinq Shine departs from continuous glucose monitors that depend on a paired smartphone app for data display. By showing readings on the patch itself, it marks a change in how glucose wearables present information to users.

For eligible adults aged 22 and older who do not use insulin, the device offers glucose readings on the wearable without a phone. The source does not state the device's price, insurance coverage, or availability dates.

The takeaway

A glucose monitor that reads out on the wearable itself lowers the setup burden for people who do not want to manage a phone app. Eligibility is limited to adults aged 22 and older who are not on insulin, so the device is not a fit for every person with diabetes.

Further reading

Explore more on Diabetes coverage and monitoring devices.

Source note: This article includes information reported by Economic Times.

Live Poll

Would you use a needle-free glucose patch that shows readings on the device?